Total Payments
$254,754
2024 Payments
$12,737
Companies
38
Transactions
1,077
Medicare Patients
2,867
Medicare Billing
$398,363
Payment Breakdown by Category
Other$195,708 (76.8%)
Food & Beverage$28,611 (11.2%)
Consulting$20,656 (8.1%)
Travel$9,265 (3.6%)
Education$515.17 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $195,708 | 107 | 76.8% |
| Food and Beverage | $28,611 | 844 | 11.2% |
| Consulting Fee | $20,656 | 11 | 8.1% |
| Travel and Lodging | $9,265 | 101 | 3.6% |
| Education | $515.17 | 14 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $105,038 | 252 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $44,427 | 121 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $44,314 | 58 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $22,455 | 39 | $0 (2019) |
| Insmed, Inc. | $13,372 | 56 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $11,003 | 135 | $0 (2024) |
| GlaxoSmithKline, LLC. | $4,967 | 97 | $0 (2024) |
| Baxter Healthcare | $2,043 | 51 | $0 (2024) |
| Philips Electronics North America Corporation | $1,861 | 84 | $0 (2023) |
| Advanced Respiratory, Inc | $1,163 | 34 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,737 | 97 | Boehringer Ingelheim Pharmaceuticals, Inc. ($10,176) |
| 2023 | $13,446 | 99 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,525) |
| 2022 | $28,290 | 126 | Mallinckrodt Hospital Products Inc. ($19,298) |
| 2021 | $26,832 | 104 | Boehringer Ingelheim Pharmaceuticals, Inc. ($16,403) |
| 2020 | $32,252 | 116 | Mallinckrodt Hospital Products Inc. ($14,049) |
| 2019 | $58,947 | 243 | Sunovion Pharmaceuticals Inc. ($20,469) |
| 2018 | $49,126 | 164 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17,468) |
| 2017 | $33,125 | 128 | Boehringer Ingelheim Pharmaceuticals, Inc. ($15,262) |
All Payment Transactions
1,077 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: RESPIRATORY | ||||||
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.30 | General |
| Category: RESPIRATORY | ||||||
| 12/19/2024 | Medtronic, Inc. | ENDURANT IIS (Device) | Food and Beverage | In-kind items and services | $181.67 | General |
| Category: Aortic Stent Grafts | ||||||
| 12/19/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Inflammation | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $124.48 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: Medical Device | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Respiratory | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.79 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: RESPIRATORY | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.08 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: RESPIRATORY | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Travel and Lodging | In-kind items and services | $48.99 | General |
| Category: RESPIRATORY | ||||||
| 10/02/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 739 | 1,713 | $142,301 | $99,602 |
| 2022 | 9 | 641 | 1,321 | $114,957 | $83,903 |
| 2021 | 9 | 709 | 1,626 | $138,374 | $107,085 |
| 2020 | 9 | 778 | 1,793 | $151,346 | $107,773 |
Total Patients
2,867
Total Services
6,453
Medicare Billing
$398,363
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 174 | 547 | $83,375 | $55,741 | 66.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 81 | 81 | $21,840 | $15,285 | 70.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 164 | 353 | $17,379 | $12,808 | 73.7% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 181 | 497 | $11,532 | $8,206 | 71.2% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 71 | 163 | $4,968 | $4,874 | 98.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 17 | 17 | $1,112 | $1,038 | 93.3% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 22 | 26 | $1,117 | $827.06 | 74.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 17 | 17 | $517.99 | $507.62 | 98.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 12 | $459.70 | $314.76 | 68.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 448 | $69,757 | $48,624 | 69.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 70 | 70 | $19,467 | $14,792 | 76.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 138 | 259 | $9,201 | $6,811 | 74.0% |
| 94664 | Evaluation of use of breathing device | Office | 2022 | 112 | 292 | $6,695 | $4,926 | 73.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 64 | 127 | $4,068 | $3,945 | 97.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 41 | 44 | $2,127 | $1,668 | 78.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $1,338 | $1,311 | 98.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2022 | 32 | 35 | $1,572 | $1,109 | 70.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 24 | $731.28 | $716.64 | 98.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 166 | 537 | $85,197 | $64,507 | 75.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 77 | 77 | $20,696 | $16,368 | 79.1% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 167 | 339 | $12,688 | $9,829 | 77.5% |
| 94664 | Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device | Office | 2021 | 125 | 374 | $8,941 | $6,290 | 70.4% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2021 | 73 | 168 | $5,417 | $5,396 | 99.6% |
| 94618 | Test for exercise-induced lung stress | Office | 2021 | 41 | 50 | $1,999 | $1,599 | 80.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 25 | $1,537 | $1,525 | 99.2% |
About Dr. Chaim Bernstein, M.D
Dr. Chaim Bernstein, M.D is a Pulmonary Disease healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1548262348.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chaim Bernstein, M.D has received a total of $254,754 in payments from pharmaceutical and medical device companies, with $12,737 received in 2024. These payments were reported across 1,077 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($195,708).
As a Medicare-enrolled provider, Bernstein has provided services to 2,867 Medicare beneficiaries, totaling 6,453 services with total Medicare billing of $398,363. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Brooklyn, NY
- Active Since 08/11/2005
- Last Updated 12/17/2020
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548262348
Products in Payments
- OFEV (Drug) $74,616
- ACTHAR (Biological) $66,768
- LONHALA MAGNAIR (Drug) $30,360
- UTIBRON (Drug) $10,184
- Arikayce (Drug) $9,879
- BEVESPI AEROSPHERE (Drug) $7,814
- Hillrom - Vest System Model 105 Home Care (Device) $2,043
- Utibron (Drug) $1,935
- SEEBRI (Drug) $1,851
- (8874) inCourage (Device) $1,520
- TEZSPIRE (Biological) $928.30
- TRELEGY ELLIPTA (Drug) $907.26
- NUCALA (Biological) $823.97
- STIOLTO RESPIMAT (Drug) $810.08
- DUPIXENT (Biological) $585.80
- FASENRA (Biological) $541.15
- SYMBICORT (Drug) $479.12
- FASENRA (Drug) $465.65
- BREZTRI (Drug) $449.59
- Life 2000 Ventilation System (Device) $431.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Brooklyn
Dr. Boris Sagalovich, Md, MD
Pulmonary Disease — Payments: $253,577
Pulmonary Disease $253,577
Dr. Maurice Alwaya, Md, MD
Pulmonary Disease — Payments: $22,286
Pulmonary Disease $22,286
Aron Rubin, Md, MD
Pulmonary Disease — Payments: $17,669
Pulmonary Disease $17,669
Elliott Bondi, Md, MD
Pulmonary Disease — Payments: $16,602
Pulmonary Disease $16,602
Dr. Mohammad Zaman, Md, MD
Pulmonary Disease — Payments: $12,861
Pulmonary Disease $12,861
Erum Zahid, Md, MD
Pulmonary Disease — Payments: $11,899
Pulmonary Disease $11,899